PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA: A COST-EFFECTIVENESS ANALYSIS
A. Raymakers
◽
S. Costa
◽
S.J. Peacock
◽
D. Regier
2016 ◽
Vol 9
(1)
◽
pp. 3-14
◽
G. R. Khachatryan
◽
D. V. Fedyaev
◽
M. V. Avxentyeva
◽
V. S. Dombrovskiy
2016 ◽
Vol 19
(7)
◽
pp. A734
◽
GR Khachatryan
◽
D Fedyaev
◽
M Avxentyeva
◽
VS Dombrovskiy
Mostafa Habibian
◽
Mehdi dehghani
2012 ◽
Vol 19
(2)
◽
pp. 204.3-205
A. Dominguez-Gil
◽
A. Alegre
◽
A. Lopez
◽
I. Oyagüez
◽
L. Gutierrez
◽
...
2009 ◽
Vol XIII
(3)
◽
pp. 18-21
◽
Anca Lupu
◽
Ciprian-Paul Radu
◽
Bogdan Pana
◽
Cristina Kalfas
2013 ◽
Vol 16
(7)
◽
pp. A589
E.A. Wehler
◽
S.P. Bilir
◽
D. Bertwistle
◽
V. Leyva
◽
J. Munakata
2014 ◽
Vol 17
(3)
◽
pp. A83
Z. Desanvicente-Celis
◽
C.A. Obando
◽
E. Rodriguez
◽
L. Gonzalez
◽
D. Muschett
2014 ◽
Vol 17
(3)
◽
pp. A85
Z. Desanvicente-Celis
◽
C.A. Obando
◽
M. Chaves
◽
L. Gonzalez
◽
D. Muschett
2006 ◽
Vol 9
(3)
◽
pp. A107
2006 ◽
Vol 17
(5)
◽
pp. 785-793
◽
P. Das
◽
A.K. Ng
◽
C.C. Earle
◽
P.M. Mauch
◽
K.M. Kuntz